{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:21:54Z","timestamp":1770978114465,"version":"3.50.1"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","award":["AAP-2016-005"],"award-info":[{"award-number":["AAP-2016-005"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191211","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T18:30:59Z","timestamp":1516645859000},"page":"e0191211","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["A systematic review of regulatory and educational interventions to reduce the burden associated with the prescriptions of sedative-hypnotics in adults treated for sleep disorders"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-4963","authenticated-orcid":true,"given":"Elsa","family":"Bourcier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Korb-Savoldelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Hejblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Hindlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"ref1","first-page":"1","article-title":"The world medicines situation 2011","author":"K Holloway","year":"2011"},{"key":"ref2","unstructured":"World Health Organization. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala Monitoring Centre\u2014WHO collaboration Centre for International Drug Monitoring, EQUUS, London, 2000:1\u201328."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2125.2012.04410.x","article-title":"Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study","volume":"75","author":"CM Chang","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"21","key":"ref4","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency Hospitalizations for Adverse Drug Events in Older Americans","volume":"365","author":"DS Budnitz","year":"2011","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"S Billioti de Gage","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/14740338.2015.1014796","article-title":"Is there really a link between benzodiazepine use and the risk of dementia?","volume":"14","author":"S Billioti de Gage","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study","volume":"12","author":"D Shash","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-151006","article-title":"Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data","volume":"54","author":"W Gomm","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"21","key":"ref9","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons","volume":"169","author":"JC Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/ageing\/aft089","article-title":"The elimination half-life of benzodiazepines and fall risk: two prospective observational studies","volume":"42","author":"OJ de Vries","year":"2013","journal-title":"Age Ageing"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/gerona\/60.5.622","article-title":"Psychotropic medications and risk for falls among community-dwelling frail older people: An observational study","volume":"60","author":"F Landi","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajp.158.6.892","article-title":"Hazardous benzodiazepine regimens in the elderly: Effects of half-life, dosage, and duration on risk of hip fracture","volume":"158","author":"PS Wang","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref13","unstructured":"World Health Organization. International drug monitoring: the role of national centres. WHO Technical report series n\u00b0498. Geneva: WHO 1972:1\u201348."},{"key":"ref14","unstructured":"Bush DM. Emergency Department Visits for Adverse Reactions Involving the Insomnia Medication Zolpidem. The CBHSQ Report. Rockville MD, 2013."},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","article-title":"Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper","volume":"65","author":"MK Church","year":"2010","journal-title":"Allergy"},{"issue":"21","key":"ref16","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances in H1-antihistamines","volume":"351","author":"FE Simons","year":"2004","journal-title":"New Engl J Med"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"ref18","first-page":"CD003161","article-title":"Cognitive behavioural interventions for sleep problems in adults aged 60+","author":"P Montgomery","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"ref19","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/archinte.164.17.1888","article-title":"Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison","volume":"164","author":"GD Jacobs","year":"2004","journal-title":"Arch Intern Med"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.smrv.2008.06.001","article-title":"The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies","volume":"13","author":"D Riemann","year":"2009","journal-title":"Sleep Med Rev"},{"issue":"5","key":"ref21","first-page":"487","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"S Schutte-Rodin","year":"2008","journal-title":"Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine"},{"key":"ref22","article-title":"European guideline for the diagnosis and treatment of insomnia","author":"D Riemann","year":"2017","journal-title":"J Sleep Res"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline","volume":"13","author":"MJ Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine Use in the United States","volume":"72","author":"M Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5665\/sleep.3410","article-title":"National Use of Prescription Medications for Insomnia: NHANES 1999\u20132010","volume":"37","author":"SM Bertisch","year":"2014","journal-title":"Sleep"},{"key":"ref26","unstructured":"ANSM. \u00c9tat des lieux de la consommation des benzodiaz\u00e9pines en France 2017; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ansm.sante.fr\/S-informer\/Points-d-Information\" xlink:type=\"simple\">http:\/\/ansm.sante.fr\/S-informer\/Points-d-Information<\/ext-link>. Accessed July 2017."},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/pds.621","article-title":"Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates","volume":"10","author":"R Lagnaoui","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF03262274","article-title":"Hospitalization as a turning point for sleep medication use in older adults: prospective cohort study","volume":"29","author":"A Zisberg","year":"2012","journal-title":"Drugs Aging"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00228-010-0983-2","article-title":"The use of hypnosedative drugs in a university hospital: has anything changed in 10 years?","volume":"67","author":"A Somers","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11096-007-9097-z","article-title":"Does hospitalisation affect hypnotic and anxiolytic drug prescribing?","volume":"29","author":"P Fagnoni","year":"2007","journal-title":"Pharm World Sci"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1192\/bjp.bp.113.126003","article-title":"Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials","volume":"204","author":"RL Gould","year":"2014","journal-title":"Br J Psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1472-6963-10-321","article-title":"Improving the use of benzodiazepines\u2014is it possible? A non-systematic review of interventions tried in the last 20 years","volume":"10","author":"AJ Smith","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"A Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"J Cohen","year":"1960","journal-title":"Educational and Psychological Measurement"},{"key":"ref35","first-page":"151","article-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"J Higgins","year":"2012"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1524-475X.2004.04006.x","article-title":"A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions","volume":"1","author":"BH Thomas","year":"2004","journal-title":"Worldviews Evid Based Nurs"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/heapro\/dai022","article-title":"Criteria for the systematic review of health promotion and public health interventions","volume":"20","author":"N Jackson","year":"2005","journal-title":"Health Promot Int"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1753-6405.1995.tb00364.x","article-title":"A Controlled Trial Educational Visiting to Improve Benzodiazepine Prescribing in General-Practice","volume":"19","author":"S Deburgh","year":"1995","journal-title":"Aust J Public Health"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0895-4356(94)00238-L","article-title":"Can drug treatment be improved by feedback on prescribing profiles combined with therapeutic recommendations? A prospective, controlled trial in general practice","volume":"48","author":"K Rokstad","year":"1995","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00005650-199807000-00008","article-title":"A randomized controlled trial of a drug use review intervention for sedative hypnotic medications","volume":"36","author":"DH Smith","year":"1998","journal-title":"Med Care"},{"issue":"11","key":"ref41","first-page":"1104","article-title":"Benzodiazepine prescribing by GP registrars. A trial of educational outreach","volume":"29","author":"NA Zwar","year":"2000","journal-title":"Aust Fam Physician"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s11606-009-1013-x","article-title":"Reducing the Prescribing of Heavily Marketed Medications: A Randomized Controlled Trial","volume":"24","author":"RJ Fortuna","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199207163270306","article-title":"A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes","volume":"327","author":"J Avorn","year":"1992","journal-title":"New Engl J Med"},{"issue":"453","key":"ref44","first-page":"495","article-title":"Reducing hypnosedative prescribing in general practice on France: A longitudinal study","volume":"13","author":"P Archambault","year":"1999","journal-title":"La Revue du Praticien\u2014Medecine Generale"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1370\/afm.1319","article-title":"Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice","volume":"10","author":"JM Hoebert","year":"2012","journal-title":"Ann Fam Med"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/02813439008994941","article-title":"Intervention against long-term use of hypnotics\/sedatives in general practice","volume":"8","author":"M Holm","year":"1990","journal-title":"Scand J Prim Health Care"},{"issue":"2","key":"ref47","first-page":"74","article-title":"Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice","volume":"4","author":"VR Jorgensen","year":"2006","journal-title":"Pharm Pract"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2165\/00023210-200721110-00006","article-title":"An approach to reduce benzodiazepine and cyclopyrrolone use in general practice: a study based on a Danish population","volume":"21","author":"VR Jorgensen","year":"2007","journal-title":"CNS Drugs"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0277-9536(97)00041-5","article-title":"The treatment of insomnia through mass media: The results of a televised behavioural training programme","volume":"45","author":"A Oosterhuis","year":"1997","journal-title":"Soc Sci Med"},{"issue":"5","key":"ref50","first-page":"425","article-title":"Is hypnotic use influenced by legislation?","volume":"58","author":"C Victorri-Vigneau","year":"2003","journal-title":"Therapie"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1015142211348","article-title":"Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes","volume":"23","author":"E Eide","year":"2001","journal-title":"Pharm World Sci"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ageing\/25.6.490","article-title":"Prescribing practice and policy for hypnotics: A model of pharmacy audit","volume":"25","author":"DNW Griffith","year":"1996","journal-title":"Age Ageing"},{"issue":"7","key":"ref53","first-page":"443","article-title":"Increased hypnotics consumption in geriatrics despite the decree dated October 1991","volume":"22","author":"F Onen","year":"1997","journal-title":"La Revue de Geriatrie"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1532-5415.2006.01006.x","article-title":"Use of a computer-based reminder to improve sedative-hypnotic prescribing in older hospitalized patients","volume":"55","author":"JV Agostini","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1176\/ps.48.10.1289","article-title":"The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities","volume":"48","author":"S Borson","year":"1997","journal-title":"Psychiatr Serv"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(94)90209-7","article-title":"Impact of regulation on benzodiazepine prescribing to a low income elderly population, New York State","volume":"47","author":"LA McNutt","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"ref57","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.280.14.1249","article-title":"Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer","volume":"280","author":"M Monane","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/106002809202600417","article-title":"Impact of Triplicate Prescription Program on Psychotropic Prescribing Patterns in Long-Term Care Facilities","volume":"26","author":"SG Zullich","year":"1992","journal-title":"Ann Pharmacother"},{"issue":"4","key":"ref59","first-page":"495","article-title":"Drug utilization review of sedative\/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board","volume":"40","author":"JK Seltzer","year":"2000","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0738-3991(97)00029-3","article-title":"Physician responses to an educational intervention on improving their long-term prescribing of sedatives","volume":"31","author":"B Sleath","year":"1997","journal-title":"Patient Educ Couns"},{"issue":"6","key":"ref61","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1532-5415.1998.tb03803.x","article-title":"A nonpharmacologic sleep protocol for hospitalized older patients","volume":"46","author":"JA McDowell","year":"1998","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/fampra\/cmq007","article-title":"An intervention to improve benzodiazepine use\u2014A new approach","volume":"27","author":"AJ Smith","year":"2010","journal-title":"Fam Pract"},{"issue":"7","key":"ref63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5694\/j.1326-5377.1999.tb127781.x","article-title":"A follow-up survey of psychotropic drug use in Sydney nursing homes","volume":"170","author":"J Snowdon","year":"1999","journal-title":"Med J Aust"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5694\/j.1326-5377.1992.tb139841.x","article-title":"An attempt to influence hypnotic and sedative drug use","volume":"156","author":"DL Carey","year":"1992","journal-title":"Med J Aust"},{"issue":"5","key":"ref65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2710.2005.00674.x","article-title":"Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach","volume":"30","author":"WB Dollman","year":"2005","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"ref66","first-page":"555","article-title":"The Nelson Prescribing Project\u2014a Programmed Intervention in General-Practice in New-Zealand","volume":"7","author":"RI Ferguson","year":"1995","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1440-1819.2002.01032.x","article-title":"The flunitrazepam abuse prevention program at a general hospital in Taiwan: A descriptive study","volume":"56","author":"WW Shen","year":"2002","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"ref68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-012-1424-1","article-title":"Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries","volume":"69","author":"E Clay","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"ref69","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1532-5415.2001.49280.x","article-title":"Zolpidem use and hip fractures in older people","volume":"49","author":"PS Wang","year":"2001","journal-title":"J Am Geriatr Soc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T17:30:36Z","timestamp":1719768636000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191211"}},"subtitle":[],"editor":[{"given":"Thomas","family":"Penzel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191211","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,22]]}}}